Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
6
×
deals
6
×
detroit blog main
6
×
detroit top stories
indiana blog main
indiana top stories
investing
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
fda
clinical trials
eli lilly
pfizer
roche
takeda pharmaceutical
eidos therapeutics
johnson & johnson
What
roundup
bio
drug
ahead
asco
companies
days
drugs
fda
growing
pharmaceutical
typically
alliance
alzheimer’s
ambien
american
annual
approved
attendees
attention
bails
biotech
brand
branded
bridgebio
bristol
buy
calls
camp’s
cancer
capital
car
cash
changing
chicago
choices
city
clinical
color
combinations
Language
unset
Current search:
biotech
×
deals
×
investing
×
" detroit blog main "
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More